All In Biotech

Drug Trial Radar · NCT05436652

A Trial of Prednisolone in Combination With SPI-62 or Placebo in Subjects With Polymyalgia Rheumatica (PMR)

Last checked: Nov 19, 2026Latest source record: May 11, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

66

Actual

Start

Jul 22, 2022

Primary completion

Apr 25, 2025

Study completion Apr 25, 2025

Sponsor

Lead sponsor
Sparrow PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Jun 29, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Sequential
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This will be a single-blind, placebo-controlled phase 2 trial to compare prednisolone effects with and without SPI-62 in participants with PMR.

Conditions

  • Polymyalgia Rheumatica

Interventions

  • SPI-62Drug

    11β hydroxysteroid dehydrogenase type 1 (HSD-1) inhibitor

  • SPI-62 matched placeboDrug

    Inactive tablets identical in appearance to SPI-62 tablets

  • Prednisolone 10mgDrug

    Standard of care prednisolone

  • Additional prednisoloneDrug

    Over encapsulated prednisolone

  • Additional prednisolone matched placeboDrug

    Inactive capsules identical in appearance to over encapsulated prednisolone

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Erythrocyte sedimentation rateTime frame: Baseline to Day 28
  2. C-reactive proteinTime frame: Baseline to Day 28
  3. Plasma fibrinogenTime frame: Baseline to Day 28

Locations

10 sites in 2 countries. Site status is shown where the registry gives one.

  • Universitätsmedizin Berlin, Medizinische Klinik mit Schwerpunkt Rheumatologie und klinische Immunologie

    Berlin, Germany

  • Internistische Praxisgemeinschaft Rheumatologie Nephrologie

    Erlangen, Germany

  • Hamburger Rheuma Forschungszentrum II im MVZ für Rheumatologie und Autoimmunmedizin

    Hamburg, Germany

  • Katholische Kliniken Rhein-Ruhr am Marien Hospital, Universitätsklinik der Ruhr-Universität

    Herne, Germany

  • Universitätsmedizin der Johannes Gutenberg Universität Mainz

    Mainz, Germany

  • Praxis Prof. Dr. med. Herbert Kellner

    Munich, Germany

  • NovaReuma

    Bialystok, Poland

  • The University of Gdańsk

    Gdansk, Poland

  • MICS Centrum Medyczne Warszawa

    Warsaw, Poland

  • Dolnośląski Szpital Specjalistyczny im. T. Marciniaka

    Wroclaw, Poland

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.